Wednesday, 5 March 2014

SCIENTIFIC BREAKTHROUGH: New Injections Provide Long-Lasting AIDS Protection

Scientists of two independent laboratories in Boston proved that injections of special long lasting AIDS drugs have protected monkeys from infection for weeks. This finding may be a link to a major breakthrough in stopping AIDS by preventing it.
Both studies have shown that the drugs provided 100% protection of monkeys if the antiretroviral drugs were taken monthly. Moreover, they found evidence that an injection once every three months may work too.
The tests are to be now performed on human to prove the same efficiency. In case of success, this may be the biggest breakthrough in preventing the disease as many people fail to take their daily preventive pills regularly. According to an AIDS expert of Mailman School of Public Health at Columbia University – Dr. Wafaa El-Sadr, the preliminary trial on humans will be started late this year, while a bigger one might be just years away.
According to modern studies, healthy people under high risk of getting infected, have 90% of being protected in case they take small doses of antiretroviral drugs daily.  The main cause for a person taking drugs and getting infected is in case he/she failed to take the pills every day without any fail. The trials that gave these results were held on gay men, intravenous drug users and couples with one of the partners being infected.

Such results were the same with trials run on African women. Some of the women claimed they were afraid of side effects of pills, while others were afraid someone might see the pills and assume they were already infected. If these women had instead got a shot once every three month, this could change the situation drastically. As practice has shown, women from developing countries are ready for this as some are already receiving shots of long-lasting birth control. Most scientists believe this is a great example of how it might work.
The studies on monkeys included injections, washes and placebos and helped scientists to not only prove the drug is effective, but also to find the correct amount of medicine that has to be in the blood to prevent the infection.
The human trial, which is to be launched in the end of this year, will include 175 people from U.S., South Africa, Malawi and Brazil. According to Dr.  El-Sadr, from Columbia University, this study may take up to three years before they will be able to launch a bigger trial. This is due to ethical reasons as the trial is very dangerous and most people would like to have a choice of either to take a pill or to use extra prevent methods as condoms.
Still this remains to be a very important trial which is to bring us a solution for protection from one of the most dangerous diseases.
READ MORE:  http://news.naij.com/61016.html

No comments:

Post a Comment